Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Bromoacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromoacetic Acid SCHEMBL1332022 | 0.95 | — | — | |
| Bromoacetic Acid SCHEMBL7617676 | 0.95 | — | — | |
| Bromoacetic Acid SCHEMBL23032 | 0.95 | — | — | |
| Bromoacetic Acid SCHEMBL16011275 | 0.95 | TSHR (1.00) | — | |
| Bromoacetic Acid SCHEMBL1332313 | 0.95 | — | — | |
| Bromoacetic Acid SCHEMBL1332132 | 0.95 | — | — | |
| Bromoacetic Acid SCHEMBL11476950 | 0.91 | — | — | |
| Bromoacetic Acid SCHEMBL3352165 | 0.91 | — | — | |
| Bromoacetic Acid SCHEMBL6913854 | 0.91 | — | — | |
| Bromoacetic Acid SCHEMBL4254284 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KET. (HU) | 2010-01-28 | — | — | US | claimed |
| EP-2080026-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | Avicor Kft. (HU) | 2009-07-22 | — | — | EP | claimed |
| WO-2008023208-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KFT. (HU) | 2008-02-28 | — | — | WO | claimed |
| US-12595286-B2 | Fucose-binding protein, method for producing same, and use of same | TOSOH CORPORATION (JP) | 2026-04-07 | — | — | US | disclosed |
| US-20250236657-A1 | MODIFIED RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BINDING PROTEIN, AND METHOD FOR ANALYZING AAV BASED ON INFECTIVITY | TOSOH CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| WO-2025105466-A1 | MODIFIED FC-BINDING PROTEIN AND METHOD FOR PRODUCING SAME | 東ソー株式会社 | 2025-05-22 | — | — | WO | disclosed |
| WO-2024242150-A1 | MODIFIED RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BINDING PROTEIN AND METHOD FOR PURIFYING AAV | 東ソー株式会社 | 2024-11-28 | — | — | WO | disclosed |
| EP-4467572-A1 | MODIFIED RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BINDING PROTEIN AND METHOD OF ANALYSIS OF AAV BASED ON INFECTION ABILITY | Tosoh Corporation (JP) | 2024-11-27 | — | — | EP | disclosed |
| WO-2024225177-A1 | IMMUNOGLOBULIN-BINDING PROTEIN | 東ソー株式会社 | 2024-10-31 | — | — | WO | disclosed |
| EP-3702462-B1 | Fc-BINDING PROTEIN EXHIBITING IMPROVED ALKALINE RESISTANCE, METHOD FOR PRODUCING SAID PROTEIN, ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHOD FOR SEPARATING ANTIBODY USING SAID ANTIBODY ADSORBENT | TOSOH CORP (JP) | 2024-10-09 | — | — | EP | disclosed |
| EP-3584257-B1 | FC-BINDING PROTEIN HAVING IMPROVED ANTIBODY SEPARATION ABILITY, AND METHOD FOR SEPARATING ANTIBODY USING SAME | TOSOH CORP (JP) | 2024-08-07 | — | — | EP | disclosed |
| US-5308866-A | Treatment of melatonin related disorders, sleep disorders, psychological disorders | ADIR ET COMPAGNIE (FR) | 1994-05-03 | — | — | US | disclosed |
| US-5276051-A | Treatment of melatoninergic system, antiischemic agents and skin disorders using aminoalkylindole compounds | ADIR ET COMPAGNIE (FR) | 1994-01-04 | — | — | US | disclosed |
| US-5045535-A | Affinity chromatography, immunoassay, cellulose | BOEHRINGER MANNHEIM GMBH (DE) | 1991-09-03 | — | — | US | disclosed |
| US-4735937-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-04-05 | — | — | US | disclosed |
| US-4430498-A | 8-Oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene compounds | CIBA-GEIGY CORPORATION (US) | 1984-02-07 | — | — | US | disclosed |
| US-4405778-A | Process for preparing cephalosporin ethers | CIBA-GEIGY CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4402734-A | N-(HALOALKYL)-N-(CARBOXYALKYL)ANILINE DERIVATIVE | SUMITOMO CHEMICAL CO., LTD. (JP) | 1983-09-06 | — | — | US | disclosed |
| US-4212970-A | PHOTOINITIATORS | FUJI PHOTO FILM CO., LTD. (JP) | 1980-07-15 | — | — | US | disclosed |
| US-3932465-A | ANTIBIOTIC | CIBA-GEIGY CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |